The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subjective cognition in chimeric antigen receptor T-cell therapy recipients.
 
Anna Barata
Stock and Other Ownership Interests - Almirall; Grifols
 
Aasha Hoogland
No Relationships to Disclose
 
Kelly Hyland
No Relationships to Disclose
 
Anuhya Kommalapati
No Relationships to Disclose
 
Reena Jayani
No Relationships to Disclose
 
Nathalie E. Irizarry-Arroyo
No Relationships to Disclose
 
Yvelise Rodriguez
No Relationships to Disclose
 
Raviteja Alla
No Relationships to Disclose
 
Brian James
No Relationships to Disclose
 
Elizabeth Lafranchise
No Relationships to Disclose
 
Michael D. Jain
Consulting or Advisory Role - Kite/Gilead; Novartis
Travel, Accommodations, Expenses - Kite/Gilead
 
Frederick Lundry Locke
Stock and Other Ownership Interests - Cellular Biomedicine Group
Consulting or Advisory Role - Alimera Sciences; Calibr; Celgene; Cellular Biomedicine Group; EcoR1 Capital; GammaDelta Therapeutics; Gerson Lehrman Group; Novartis; WUGEN, Inc.
Research Funding - Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Heather S.L. Jim
Consulting or Advisory Role - Janssen Medical Affairs; Merck; RedHill Biopharma